SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401914-22-000085
Filing Date
2022-11-10
Accepted
2022-11-09 17:41:17
Documents
17
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dare-20221110.htm   iXBRL 8-K 36240
2 EX-99.1 dare_ex991x111022.htm EX-99.1 23889
6 dare_ex991x111022001.jpg GRAPHIC 295935
7 dare_ex991x111022002.jpg GRAPHIC 268603
8 dare_ex991x111022003.jpg GRAPHIC 435723
9 dare_ex991x111022004.jpg GRAPHIC 134308
  Complete submission text file 0001401914-22-000085.txt   1768169

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20221110.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20221110_lab.xml EX-101.LAB 23892
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20221110_pre.xml EX-101.PRE 12539
11 EXTRACTED XBRL INSTANCE DOCUMENT dare-20221110_htm.xml XML 10745
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 221374182
SIC: 2834 Pharmaceutical Preparations